Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of America

Pappas, Peter G., Kauffman, Carol A., Andes, David, Benjamin, Daniel K., Calandra, Thierry F., Edwards, John E., Filler, Scott G., Fisher, John F. +6 more·2009·Clinical Infectious Diseases

Cited by (1,018)

Items 1,001–1,018 of 1,018

  1. <i>Candida glabrata</i> : new tools and technologies—expanding the toolkit
    Ho, Hsueh-lui, Haynes, Ken · 2015 · FEMS Yeast Research
  2. Echinocandins: Addressing outstanding questions surrounding treatment of invasive fungal infections
    Holt, Shannon L., Drew, Richard H. · 2011 · American Journal of Health-System Pharmacy
  3. Antifungal resistance does not necessarily affect<i>Candida glabrata</i>fitness
    Borghi, Elisa, Andreoni, Stefano, Cirasola, Daniela, Ricucci, Valentina, Sciota, Rita, Morace, Giulia · 2014 · Journal of Chemotherapy
  4. Candida causes recurrent vulvovaginal candidiasis by forming morphologically disparate biofilms on the human vaginal epithelium
    Pan, Yihong, Sun, Yao, Chen, Lanqian, Cheng, Yali, Jin, Panpan, Zhang, Weidan, Zheng, Lingzhi, Liu, Junyan, Zhou, Tieli, Xu, Zhenbo et al. · 2023 · Biofilm
  5. Designed Antimicrobial Peptides for Recurrent Vulvovaginal Candidiasis Treatment
    Woodburn, Kathryn W., Clemens, L. Edward, Jaynes, Jesse, Joubert, Lydia-Marie, Botha, Alfred, Nazik, Hasan, Stevens, David A. · 2019 · Antimicrobial Agents and Chemotherapy
  6. Comparative in vivo dose-dependent activity of caspofungin and anidulafungin against echinocandin-susceptible and -resistant Aspergillus fumigatus
    Lewis, R. E., Liao, G., Hou, J., Prince, R. A., Kontoyiannis, D. P. · 2011 · Journal of Antimicrobial Chemotherapy
  7. Successful Treatment of Chronic Mucocutaneous Candidiasis Caused by Azole-Resistant<i>Candida albicans</i>with Posaconazole
    Firinu, Davide, Massidda, Orietta, Lorrai, Maria Maddalena, Serusi, Loredana, Peralta, Monica, Barca, Maria Pina, Serra, Paolo, Manconi, Paolo Emilio · 2011 · Clinical and Developmental Immunology
  8. Treatment practices for adults with candidemia at 9 active surveillance sites—United States, 2017–2018.
    Gold, Jeremy A W, Seagle, Emma E, Nadle, Joelle, Barter, Devra M, Czaja, Christopher A, Johnston, Helen, Farley, Monica M, Thomas, Stepy, Harrison, Lee H, Fischer, Jill et al. · 2021 · Clinical Infectious Diseases
  9. Evaluation of the safety and efficacy of micafungin in Japanese patients with deep mycosis: a post-marketing survey report
    Hanadate, Tomoko, Wakasugi, Masahiro, Sogabe, Keizo, Kobayashi, Toshimitsu, Horita, Hisanori, Kawamura, Ikuo, Matsui, Keita, Sou, Masahiro, Hori, Yasuhiro, Hoshino, Yo · 2011 · Journal of Infection and Chemotherapy
  10. Epidemiology and risk factors for invasive fungal disease in liver transplant recipients in a tertiary transplant center
    Lum, Lionel, Lee, Andie, Vu, Monica, Strasser, Simone, Davis, Rebecca · 2020 · Transplant Infectious Disease
  11. Antifungal Activity of Plant Secondary Metabolites on Candida albicans: An Updated Review
    Khan, Andleeb, Moni, Sivakumar Sivagurunathan, Ali, M., Mohan, Syam, Jan, Huma, Rasool, Saiema, Kamal, Mohammad A, Alshahrani, Saeed, Halawi, Maryam, Alhazmi, Hassan A · 2023 · Current Molecular Pharmacology
  12. Effects of azole treatments on the physical properties of Candida albicans plasma membrane: A spin probe EPR study
    Sgherri, Cristina, Porta, Amalia, Castellano, Sabrina, Pinzino, Calogero, Quartacci, Mike F., Calucci, Lucia · 2014 · Biochimica et Biophysica Acta (BBA) - Biomembranes
  13. Novel Sulfones with Antifungal Properties: Antifungal Activities and Interactions with Candida spp. Virulence Factors
    Gizińska, Małgorzata, Staniszewska, Monika, Ochal, Zbigniew · 2018 · Mini-Reviews in Medicinal Chemistry
  14. Treatment of invasive candidiasis: between guidelines and daily clinical practice
    Tagliaferri, Enrico, Menichetti, Francesco · 2015 · Expert Review of Anti-infective Therapy
  15. Post-antifungal effects and time-kill studies of anidulafungin, caspofungin, and micafungin against Candida glabrata and Candida parapsilosis
    Smith, Raymond P., Baltch, Aldona, Bopp, Lawrence H., Ritz, William J., Michelsen, Phyllis P. · 2011 · Diagnostic Microbiology and Infectious Disease
  16. The impact of new epidemiological cutoff values on Candida glabrata resistance rates and concordance between testing methods
    Ben-Ami, Ronen, Hilerowicz, Yuval, Novikov, Anna, Giladi, Michael · 2014 · Diagnostic Microbiology and Infectious Disease
  17. Trends of antifungal use based on sales data in Japan from 2006 to 2015
    Kawabe, Ayako, Muraki, Yuichi, Inose, Ryo, Kusama, Yoshiki, Goto, Ryota, Ebisui, Ai, Ishii, Saki, Ishikane, Masahiro, Ohge, Hiroki, Ohmagari, Norio · 2020 · Biological and Pharmaceutical Bulletin
  18. Mitochondrial complex III subunit Qcr8 regulates the virulence and adhesion of <i>Candida albicans</i> by modulating mitochondrial function
    Zhao, Qianjun, Huang, Xiaotian, Liu, Qiong, Cao, Yanli, Yu, Xiaomin, Liu, Yanling, Hu, Niya, Han, Zhenning, Tan, Junjun, Li, Xuan et al. · 2026 · Microbiology Spectrum